NewLake Capital: A 12% Dividend with Real Coverage — A Tactical Long

Hook & thesis

NewLake Capital Partners (NLCP) is paying a quarterly cash dividend of $0.43 per share that annualizes to $1.72 — producing a current yield north of 12% at roughly $13.84. That headline yield looks scary at first glance for a cannabis-focused REIT, but the company's most recent results show AFFO of $2.09 per share for the full year and $0.51 in Q4 2025, meaning the dividend is currently covered at about 82%. Couple that with $106.3 million of available liquidity and minimal leverage, and the distribution looks materially safer than the market's price action implies.

My thesis: buy NLCP around the current price as a tactical income-and-recovery trade. The risk/reward favors a disciplined long because the dividend has demonstrable AFFO coverage, balance-sheet flexibility to manage tenant churn in the near term, and technicals that are oversold. Still, this is a volatile, niche REIT and the position should be managed with a hard stop.

What NewLake does and why it matters

NewLake Capital Partners provides real estate capital to state-licensed cannabis operators, owning a portfolio of 34 properties split between cultivation facilities (15) and dispensaries (19). It operates in a market where tenants can experience episodic dislocations due to regulatory, retail, or operator-specific issues — the company noted tenant dislocations involving AYR Wellness and Revolutionary Clinics — but its business model is landlord-focused: long-term leases and structured financing to licensed operators.

For investors, the main fundamental driver is AFFO per share and liquidity. As a REIT-like vehicle focused on cannabis real estate, cash flow stability and covenant-compliant tenants determine ability to sustain dividends. NewLake reported full-year 2025 revenue of $51.1 million and AFFO of $2.09 per share. Q4 2025 produced $12.3 million in revenue and AFFO of $0.51 per share. The company declared a Q1 2026 dividend of $0.43 per share, continuing a steady quarterly payout cadence.

Supporting data points

• Revenue: $12.3M in Q4 2025 and $51.1M for full-year 2025.
• AFFO: $0.51 per share in Q4 2025 and $2.09 per share for the full year 2025.
• Liquidity: $106.3M on the balance sheet with minimal debt.
• Dividend: $0.43 per quarter, annualized $1.72 per share. At $13.84/share that implies a ~12.4% yield.
• Portfolio: 34 properties (15 cultivation, 19 dispensaries) providing geographic and asset-type exposure within the cannabis sector.

Valuation framing

There is no market cap provided here, but valuation can be framed by income mechanics. AFFO of $2.09 vs. an annual dividend of $1.72 gives a payout ratio of ~82%. For a specialized REIT that operates in a higher-risk sector, that payout ratio is reasonable — not conservative, but not immediately unsustainable either, provided AFFO trends hold and the company avoids large tenant defaults.

Market participants appear to be pricing in more downside: the stock is trading below its short-term moving averages (SMA10: $14.48, SMA20: $14.95, SMA50: $15.30) and momentum indicators are oversold (RSI ~24.2). That technical dislocation, combined with predictable quarterly cash flows and ample liquidity, creates an asymmetric setup — income today plus potential capital recovery if operational headwinds moderate.

Trade plan (actionable)

Entry: Buy NLCP at $13.84. This is the current market level and captures the high yield without chasing a recovery premium.

Stop loss: $12.50. A breach below $12.50 would indicate deeper seller conviction and would reduce the trade's risk/reward materially; exit to limit downside.

Target: $16.50. This target captures a meaningful improvement toward recent moving averages and allows for upside from yield compression or improved operational results.

Time horizon: mid term (45 trading days). I expect a multi-week consolidation/bounce trade: time to collect at least one quarterly dividend cycle risk-adjusted and to allow market sentiment to respond to either incremental operational updates or market technical mean reversion. If catalysts accelerate upside, the position can be trimmed into strength before the 45-day mark.

Why this sizing and horizon: The plan is tactical: the dividend yields ~12% today, so even if the stock is range-bound the cash return is significant. The 45-trading-day horizon gives time for operational news or improved liquidity deployment to be digested by the market while keeping the position short of a full-term re-rating risk if the cannabis sector remains muted.

Catalysts

• Consistent dividend declarations - continued quarterly dividends at $0.43 will keep income-oriented buyers interested and reduce forced selling pressure.
• Improving tenant performance or resolution of AYR Wellness/Revolutionary Clinics dislocations could materially improve AFFO visibility and reduce perceived credit risk.
• Asset-level or portfolio-level balance-sheet actions (e.g., opportunistic acquisitions using the $106.3M liquidity, or asset sales at premium) that demonstrate active portfolio management and leverage discipline.
• Technical mean reversion from oversold conditions (RSI ~24) and buyer interest from yield-seeking funds could compress yield and lift the share price toward moving averages.

Risks

• Tenant credit risk: Cannabis operators remain exposed to regulatory changes and operating challenges. A major tenant default would directly pressure cash flow and AFFO, threatening the dividend.
• Industry/regulatory risk: State-level rule changes, banking limitations, or adverse tax treatment for cannabis operators could reduce tenant profitability and increase vacancy or rent renegotiation pressure.
• Dividend sustainability: Although AFFO covered the dividend in 2025, AFFO can be volatile. A sustained decline in AFFO would force a cut or suspension, which would be highly punitive to the share price.
• Market liquidity and volatility: Short interest and elevated short-volume days show the name can move quickly on sentiment. Price action can be exaggerated in either direction, increasing execution risk and stop-loss slippage.
• Concentrated portfolio exposure: With 34 properties in a niche sector, single-asset shocks can disproportionately affect results compared to diversified REITs.

Counterargument: The headline 12% yield could be a classic yield trap. If AFFO falls meaningfully below $2.09 per share due to a wave of tenant defaults or lease restructurings, the company could be forced to cut the dividend or draw on liquidity — either outcome would likely produce a sharp share-price decline. That scenario is plausible in a stressed cannabis cycle and should not be dismissed.

How I would change my mind

I would materially reduce the conviction on this trade if any of the following occurs: AFFO guidance or realized AFFO declines below $1.40 annualized (which would inflate the payout ratio toward or above 120%); the company starts drawing significantly on liquidity to meet ordinary expenses or debt covenants; or management reverses its payout policy and signals a multi-quarter suspension. Conversely, I would increase exposure if AFFO prints showing sequential recovery, tenant cures are announced for previously troubled assets, or management deploys liquidity in accretive ways that increase recurring cash flow.

Conclusion

NLCP offers an attractive income entry point for investors willing to accept sector-specific risk. The dividend has measurable coverage from AFFO and the company has healthy liquidity — two tangible safety factors in a high-yield name. The trade is not without real downside: tenant defaults, regulatory shocks, or AFFO deterioration would be decisive negatives. For disciplined traders and income-oriented investors comfortable with cannabis-sector exposure, a long at $13.84 with a $12.50 stop and $16.50 target over a mid-term (45 trading days) horizon provides a clear-risk plan to capture both yield and potential capital recovery.

Key operational facts at a glance

Trade idea: Buy NLCP at $13.84, stop $12.50, target $16.50, mid-term (45 trading days). Risk level: medium.